Kiniksa Pharmaceuticals International, plc (KNSA)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
63. 95
+2.84
+4.6474%
$
4.66B Market Cap
84.4 P/E Ratio
- Div Yield
712,400 Volume
-0.16 Eps
$ 61.11
Previous Close 
Want to track KNSA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 0.32 | - |
| | | 0.35 | 0.17 |
| | | 0.31 | 0.23 |
| | | 0.19 | 0.23 |
| | | 0.28 | 0.11 |
| | | 0.13 | - |
| | | 0.03 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
KNSA Earnings Reports FAQ
What is the earnings per share (EPS) for KNSA?
The current EPS is -0.16.
What is the company's earnings growth rate?
Kiniksa Pharmaceuticals International, plc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Kiniksa Pharmaceuticals International, plc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Kiniksa Pharmaceuticals International, plc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for KNSA at this time, as Kiniksa Pharmaceuticals International, plc has no recent EPS data to calculate it.
